InsiderWatch
Get Started

Lauren Rusckowski Duprey Insider Trades

Chief Transformation Officer

Chief Transformation Officer at Takeda Pharmaceutical Co LTD. 2 significant open-market trades reported on SEC Form 4 in the last 180 days.

On EDGAR, this filer has 4 Form 4 filings on record since 2026, the latest on Sep 15, 2026. Full history on sec.gov

$0

Bought

$1.5M

Sold

0 / 2

Buys / Sells

1

Companies

Companies

  • TAKChief Transformation Officer

    Takeda Pharmaceutical Co LTD

    2 sells, $1.5M · 4 graded alerts

Reported Trades

Open-market transactions only (code P and S), outside any 10b5-1 plan, dated by the day the filing reached EDGAR. Each row links to the filing.

FiledCompanyTradeValue
Sep 15, 2026TAKChief Transformation Officersell15.3% of stake$640K
Aug 12, 2026TAKChief Transformation Officersell17.4% of stake$814K

Other Insiders at These Companies

Everyone else who reported a significant open-market trade at the same company in the last 180 days. Several buyers inside one week is cluster buying.

How to Read This Page

These are the trades an insider chose to make with their own money, not grants, option exercises or tax withholding. A purchase is the stronger signal (why buys carry more information than sales), and an insider who buys is locked out of selling for six months by the short-swing rule. Several insiders buying at the same company in the same week is cluster buying, the pattern the research literature rates highest. The window here is 180 days; the full filing history lives on EDGAR.

Get this insider's next buy the minute it files

InsiderWatch reads every Form 4 as it reaches EDGAR, keeps the open-market buys that matter, and sends them by email and Telegram.

Try free for 7 days

Every call scored in public, misses included.